| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |